Hannah Newnes

Hannah Newnes is a Research Associate at the School of Biomedical Sciences, The University of Western Australia. Her work focuses on immunology and cancer research, particularly the role of type I interferons in antitumor immunity and immunotherapy. She is affiliated with the University of Western Australia (M503) and holds an ORCID ID (0000-0003-1647-975X).

• Current position: Research Associate
• Institution: The University of Western Australia
• Research focus: Immunotherapy, Tumor Microenvironment, Interferon Signaling

Research Interests: Hannah's research explores how type I interferons modulate immune responses in cancer contexts. Key areas include:

• Differential activation of immune cells (T cells, NK cells) via interferon subtypes
• Mechanisms linking burn injury to cancer incidence
• Overcoming therapeutic resistance in tumor microenvironments
• Immunomodulatory cytokines (e.g., interleukin-4) in cancer treatment
• Systems-level understanding of immune-cancer interactions
• Translational immunotherapy for solid cancers

Research Output Trends: Her publications (9 total) span 2021–2025, with recent emphasis on type I interferon subtypes, T cell activation, and tumor microenvironment in high-impact journals like Science Advances and Cancers. Collaborative work with teams across immunology, oncology, and biomedical sciences dominates her output.

Grants: She contributed to a Cancer Council WA-funded project (2024–2025) titled Enhancing T cell-based immunotherapies for solid cancers.

Contact: Email: hannah.newnes@uwa.edu.au